Membrane changes in cells from myotonia patients.
Rüdel
R
R
Lehmann-Horn
F
F
D000200:Action Potentials; D000251:Adenosine Triphosphatases / Q000378:metabolism; D000873:Anthracenes; D002712:Chlorides / Q000378:metabolism; D004576:Electromyography; D004777:Environment; D004910:Erythrocyte Membrane / Q000502:physiology*; D006801:Humans; D007328:Insulin / Q000502:physiology; D007473:Ion Channels / Q000502:physiology; D008566:Membranes / Q000502:physiology; D009132:Muscles / Q000473:pathology / Q000503:physiopathology; D009222:Myotonia / Q000139:chemically induced / Q000188:drug therapy / Q000503:physiopathology*; D009224:Myotonia Congenita / Q000378:metabolism; D009223:Myotonic Dystrophy / Q000378:metabolism / Q000503:physiopathology; D009469:Neuromuscular Junction / Q000503:physiopathology; D010009:Osteochondrodysplasias / Q000503:physiopathology; D010243:Paralysis / Q000503:physiopathology; D010474:Percussion; D010507:Periodicity; D010812:Physical Stimulation; D011188:Potassium / Q000097:blood / Q000378:metabolism; D012964:Sodium / Q000378:metabolism; D013577:Syndrome; D013696:Temperature; D009626:Terminology as Topic
D000873:Anthracenes; D002712:Chlorides; D007328:Insulin; D007473:Ion Channels; C010030:9-anthroic acid; D012964:Sodium; D000251:Adenosine Triphosphatases; D011188:Potassium